Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial

BACKGROUND: The incidence of herpes zoster is up to 9 times higher in immunosuppressed solid organ transplant recipients than in the general population. We investigated the immunogenicity and safety of an adjuvanted recombinant zoster vaccine (RZV) in renal transplant (RT) recipients ≥18 years of ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Vink, Peter, Ramon Torrell, Josep Maria, Sanchez Fructuoso, Ana, Kim, Sung-Joo, Kim, Sang-il, Zaltzman, Jeff, Ortiz, Fernanda, Campistol Plana, Josep Maria, Fernandez Rodriguez, Ana Maria, Rebollo Rodrigo, Henar, Campins Marti, Magda, Perez, Rafael, González Roncero, Francisco Manuel, Kumar, Deepali, Chiang, Yang-Jen, Doucette, Karen, Pipeleers, Lissa, Agüera Morales, Maria Luisa, Rodriguez-Ferrero, Maria Luisa, Secchi, Antonio, McNeil, Shelly A, Campora, Laura, Di Paolo, Emmanuel, El Idrissi, Mohamed, López-Fauqued, Marta, Salaun, Bruno, Heineman, Thomas C, Oostvogels, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938982/
https://www.ncbi.nlm.nih.gov/pubmed/30843046
http://dx.doi.org/10.1093/cid/ciz177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938982/
https://www.ncbi.nlm.nih.gov/pubmed/30843046
http://dx.doi.org/10.1093/cid/ciz177

Ejemplares similares